Thalassemia is widely distributed throughout the world and is one of t
he major public health problems. The use of bone marrow transplantatio
n, the only curative therapy for thalassemia, is limited because less
than 30% of the patients have unaffected and HLA-identical siblings as
donors. Cord blood stem cells, an alternative source of stem cells fo
r transplantation, have been successfully transplanted into patients w
ith several diseases after myeloablative therapy. Twenty cord blood sa
mples from unaffected neonates whose siblings had severe thalassemia w
ere collected, The median volume was 80 ml. The median number of cells
and colony forming units-granulocyte-macrophage in cord blood was 9.2
x 10(8) and 3.4 x 10(5), respectively. Four of 20 cord blood samples
had HLA-matched to the affected siblings, One patient underwent cord b
lood transplantation with success; one patient is waiting for transpla
ntation.